Skip to content
Cour Pharmaceuticals
  • Careers
  • Contact Us
  • Linkedin
  • Twitter
  • Home
  • About
    • The COUR Team
    • Medical & Science Partners
    • Product Development
  • Pipeline
    • CNP-101/TAK-101 (Celiac Disease)
    • CNP-201 (Peanut Allergy)
    • CNP-104 (Primary Biliary Cholangitis)
    • CNP-T1D (Type 1 Diabetes)
    • CNP-MYG (Myasthenia Gravis)
    • CNP-ITP (Immune Thrombocytopenia Purpura)
  • Technology
    • COUR Nanoparticle Platform
    • Immune Reprogramming
  • Therapeutic Areas
    • Autoimmune Diseases: Celiac
    • Food & Environmental Allergies: Peanut Allergy
    • Rare Diseases: Primary Biliary Cholangitis
    • Autoimmune Diseases: Type 1 Diabetes
    • Rare Diseases: Myasthenia Gravis
    • Rare Diseases: Immune Thrombocytopenia Purpura
    • Protein Replacement: Gene Therapy
  • Partners & Collaborators
  • Media & Publications
    • Press Releases
    • Scientific Publications
    • Corporate Deck
  • Videos
    • Technology
    • Autoimmune Disease
    • Food and Environmental Allergies
    • Gene Therapy

Press Releases

    •  
    •  
Cour Pharmaceuticals

Press Releases

October 19, 2015

Cour Pharmaceuticals Releases Data on Potential Breakthrough Treatment for Celiac Disease

Proprietary Antigen-specific Nanoparticles and Cure for Celiac Disease Chicago (June 22, 2015) – Cour Pharmaceutical Development Company today announced new data from a preclinical live animal study demonstrating a breakthrough...
Read More
« Previous 1 2
  • 888-551-COUR
    888-551-2687

Connect

Connect

Pipeline

  • Pipeline
  • CNP-101/TAK-101 (Celiac Disease)
  • CNP-201 (Peanut Allergy)
  • CNP-104 (Primary Biliary Cholangitis)
  • CNP-T1D (Type 1 Diabetes)
  • CNP-MYG (Myasthenia Gravis)
  • CNP-ITP (Immune Thrombocytopenia Purpura)

Technology

  • Technology
  • COUR Nanoparticle Platform
  • Immune Reprogramming
  • Videos
  • Technology
  • Autoimmune Disease
  • Food and Environmental Allergies
  • Gene Therapy
  • Media & Publications
  • Press Releases
  • Scientific Publications
  • Corporate Deck

Therapeutic Areas

  • Therapeutic Areas
  • Autoimmune Diseases: Celiac
  • Food & Environmental Allergies: Peanut Allergy
  • Rare Diseases: Primary Biliary Cholangitis
  • Autoimmune Diseases: Type 1 Diabetes
  • Rare Diseases: Myasthenia Gravis
  • Rare Diseases: Immune Thrombocytopenia Purpura
  • Protein Replacement: Gene Therapy
close ×
CNP-101/TAK-101 (Celiac Disease) CNP-201 (Peanut Allergy) CNP-104 (Primary Biliary Cholangitis) CNP-T1D (Type 1 Diabetes) CNP-MYG (Myasthenia Gravis) CNP-ITP (Immune Thrombocytopenia Purpura)
  • About
  • Partners & Collaborators
  • Careers
  • Contact Us
  • Sitemap
Website by Axxiem
© Copyright . All Right Reserved
Privacy | Terms of Use